Krenitsky Pharmaceuticals
KPI is a clinical-stage biopharma company focused on the development of new medicines that have the potential to transform the standard of care and save or improve patients’ lives. Our pipeline includes TriRima, a reversible inhibitor of monoamine oxidase-A (RIMA) for the treatment of depression, and KP544, a novel mechanism for the treatment of neurodegenerative disorders such as Alzheimer's Disease and prevention of neuropathy caused by chemotherapeutic agents.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Krenitsky Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Krenitsky Pharmaceuticals
1 distinct titles indexed · top 1 shown.
- 1board member
Sign up to unlock all 1 contacts at Krenitsky Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Krenitsky Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.